Organon is an independent global health care company which specializes in three core areas: women’s health products with a focus on contraception and fertility, biosimilars, and established medicines. The company’s portfolio offers over 70 medicines and products for reproductive health, dermatology, cardiovascular disease, neurology, autoimmune and respiratory conditions. Organon’s R&D efforts concentrate on addressing conditions that primarily affect women, including maternal and peripartum conditions, endometriosis, polycystic ovarian syndrome, menopause, and migraines.
Courtesy of Organon